Myomo (MYO)
(Real Time Quote from BATS)
$3.78 USD
+0.02 (0.53%)
Updated Sep 5, 2024 01:44 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Income Statements
Fiscal Year end for Myomo, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 19 | 16 | 14 | 8 | 4 |
Cost Of Goods | 6 | 5 | 4 | 3 | 1 |
Gross Profit | 13 | 10 | 10 | 5 | 3 |
Selling & Adminstrative & Depr. & Amort Expenses | 21 | 21 | 21 | 15 | 14 |
Income After Depreciation & Amortization | -8 | -11 | -10 | -11 | -11 |
Non-Operating Income | 0 | 0 | 0 | -1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -8 | -11 | -10 | -12 | -11 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -8 | -11 | -10 | -12 | -11 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -8 | -11 | -10 | -12 | -11 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -10 | -10 | -10 | -11 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -8 | -11 | -10 | -11 | -11 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.50 | 7.05 | 5.83 | 3.33 | 0.55 |
Diluted EPS Before Non-Recurring Items | -0.28 | -1.52 | -1.89 | -3.46 | -19.35 |
Diluted Net EPS (GAAP) | -0.28 | -1.52 | -1.89 | -3.67 | -19.35 |
Fiscal Year end for Myomo, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 7.52 | 3.75 | 4.76 | 5.08 | 5.96 |
Cost Of Goods | 2.20 | 1.46 | 1.65 | 1.59 | 1.68 |
Gross Profit | 5.33 | 2.30 | 3.10 | 3.49 | 4.28 |
SG&A, R&D, and Dept/Amort Expenses | 6.44 | 6.19 | 5.54 | 5.52 | 5.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.11 | -3.89 | -2.44 | -2.03 | -1.10 |
Non-Operating Income | 0.11 | 0.14 | 0.04 | 0.04 | 0.09 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -1.01 | -3.75 | -2.39 | -1.98 | -1.02 |
Income Taxes | 0.11 | 0.08 | 0.07 | 0.05 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.12 | -3.84 | -2.46 | -2.03 | -1.01 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.12 | -3.84 | -2.46 | -2.03 | -1.01 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 37.37 | 36.75 | 35.18 | 35.27 | 27.99 |
Diluted EPS Before Non-Recurring Items | -0.03 | -0.10 | -0.07 | -0.06 | -0.04 |
Diluted Net EPS (GAAP) | -0.03 | -0.10 | -0.07 | -0.06 | -0.04 |